🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

7 recruiting trials

for Drug Susceptible Pulmonary Tuberculosis

Shortened Regimen for Drug-susceptible TB in Children NCT06253715Phase 39 sites📍 Chennai📍 Pune📍 Bandung Johns Hopkins University · Tests: Isoniazid, Rifampin, Pyrazinamide, Ethambutol, Rifapentine A PAN-USR TB Multi-Center Trial NCT06905522Phase 33 sites📍 Beijing📍 Shenzhen📍 Ürümqi Shenzhen Third People's Hospital · Tests: Bedaquiline (B), Sitafloxacin (S), Linezolid (L), Pyrazinamide (Z), Isoniazid (H) A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide NCT06748937Phase 21 site📍 Cape Town TASK Applied Science · Tests: Alpibectir 45 mg once daily (OD) plus Ethionamide 125 mg OD, Alpibectir 45 mg OD plus Ethionamide 250 mg OD, Isoniazid,… Effect of Peer-led Educational Intervention on Treatment Outcomes Among Adults With Drug-susceptible Pulmonary Tuberculosis in South Omo and Ari Zone, Southern Ethiopia NCT07387601NA1 site📍 Jinka Bahirdar University · Tests: peer-led education Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis NCT07525427Phase 213 sites📍 Durban📍 George📍 Johannesburg Gates Medical Research Institute · Tests: Bedaquiline, pretomanid and TBD09, Bedaquiline, pretomanid and TBD09, Bedaquiline, pretomanid and TBD09, Bedaquiline, p… Novel Triple-dose Tuberculosis Retreatment Regimen NCT04260477Phase 31 site📍 Niamey Institute of Tropical Medicine, Belgium · Tests: 6EH³R³Z, 6EHRZ A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis NCT07209761Phase 342 sites📍 Beijing📍 Fuzhou📍 Shenzhen Otsuka Pharmaceutical Development & Commercialization, Inc. · Tests: Bedaquiline, Quabodepistat, Pretomanid, Moxifloxacin, Linezolid
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy